HHS is creating a pathway for health care organizations to self-disclose civil violations of the False Claims Act. 
 
The Healthcare False Claims Act Self-Disclosure Pilot Program was announced Oct. 22, 2026, and will run for six months. Under the program, companies disclosing violations will be required to disclose all relevant details, submit documentation related to misconduct and name all remedial steps they’ve enacted.  
 
Companies will then be required to make a repayment, with a penalty. In exchange, companies will receive a release from DOJ for the disclosed potential False Claims Act violations, the HHS Office of Inspector General (OIG) will not impose an exclusion or require a Corporate Integrity Agreement as part of the resolution, and CMS not revoke the provider’s or supplier’s enrollment and billing privileges, and neither CMS nor OIG will impose civil monetary penalties. 
 
“Companies that identify and report potential violations should have a clear way to correct them, repay the government and continue serving people in federal healthcare programs,” noted Dr. Mehmet Oz, CMS administrator, in an HHS press release. “This pilot creates a defined path to accountability while helping CMS focus its enforcement resources on fraud.”
  
Self-disclosures will be accepted electronically until April 22, 2027.